A multicultural group practicing yoga together in a bright studio

Oak vs TMates: GLP-1 Comparison 2026

Oak vs TMates: pricing, medication type, clinical support, and which mid-market GLP-1 patient each program fits. Both programs’ prices verified July 2026 or later; each price carries its own date in the table below.

By RangeYourselfUpdated July 14, 20264 min read

Quick answer

Oak and TMates both offer GLP-1 telehealth, but they package medication, support, and pricing differently. The right choice depends on whether you weight cost, clinical touch, or formulation flexibility highest.

Side-by-side comparison

Feature	Oak	TMates
Best for	Compounded GLP-1 shoppers comparing cash-pay options	Compounded GLP-1 with hands-on clinical touch
Medication type	Compounded semaglutide and tirzepatide, injectable and sublingual (Oak Longevity)	Compounded GLP-1 with bundled clinical support
Pricing model	Cash-pay subscription; recurring price not consistently listed publicly (advertised $119–$190/mo under promos)	Monthly subscription, dose-tier pricing
Semaglutide price	Compounded, advertised from $119/mo (promo); recurring rate not consistently listed, confirm in enrollment	From $158/mo (compounded semaglutide, 12-month plan; $249/mo month-to-month); medication and visits included
Tirzepatide price	Compounded, advertised from $185/mo (promo); recurring rate not consistently listed, confirm in enrollment	From $167/mo (compounded tirzepatide, 12-month plan; $297/mo month-to-month)
Key watchout	Oak advertises figures from $119 to $190/mo across its own pages under promotions and does not list one consistent recurring price, confirm the exact ongoing rate in the enrollment flow before subscribing. Fees are non-refundable once charged.	The $158 headline is the compounded SEMAGLUTIDE plan (12-month term; $249/mo month-to-month). Tirzepatide costs more ($167/mo on a 12-month plan, $297 month-to-month), confirm your product and term at checkout
Price checked	Checked by a person July 12, 2026	Checked by a person July 14, 2026 · an automated check re-read it September 3, 2026

When to choose Oak

You want compounded semaglutide or tirzepatide (injectable or sublingual) on a cash-pay plan
You're comfortable confirming the exact recurring price in Oak's enrollment flow rather than on the public site
You prefer async care with no video visit required
You want same-day provider review and free shipping

Check current Oak pricing →

When to choose TMates

You want a compounded program with clinical check-ins built in
You'd rather pay one bundled monthly fee than line items
You want responsive messaging with prescribers
You're comfortable with a longer onboarding intake in exchange for support

Check current TMates pricing →

Full reviews

Frequently asked questions

Is Oak cheaper than TMates?

Neither Oak nor TMates is uniformly cheaper, both publish dose-banded and formulation-banded pricing that depends on the exact product, dose, and any insurance pathway. Compare the specific tier you'd be on at each before deciding.

Which is better for semaglutide or tirzepatide, Oak or TMates?

Both Oak and TMates prescribe semaglutide and tirzepatide where appropriate. Choose based on how each program handles your target medication, not just the entry price.

Are Oak and TMates compounded or brand-name?

Oak offers compounded semaglutide and tirzepatide, injectable and sublingual (oak longevity). TMates offers compounded glp-1 with bundled clinical support. If you specifically want brand-name Wegovy or Zepbound, lean toward whichever explicitly supports brand access; if compounded is fine, both can typically meet that need.

Can I switch from Oak to TMates?

Yes, switching between Oak and TMates is straightforward in most states. You typically finish your current month, complete a new intake with the other provider, and they handle the prescription. Watch for overlap on auto-renewal billing and confirm any dose-tier or formulation differences with the new clinician before your next shipment.

Compare Oak and TMates to other programs

Alert me when this gets cheaper

These prices move. Get one email when we publish a verified price drop, the programs on this list included. No spam. Unsubscribe any time.

Related guides

About compounded GLP-1 medicationsCompounded semaglutide and tirzepatide are not FDA-approved finished products. They are prepared by state-licensed 503A pharmacies or 503B outsourcing facilities and are not individually reviewed by the FDA for safety, effectiveness, or quality. Compounders describe these preparations as using the same active ingredient as the approved medicines; the FDA has warned that some compounded products use salt forms, semaglutide sodium or semaglutide acetate, that it considers different active ingredients from the approved drug, and has issued warning letters over marketing that presents a compounded preparation as interchangeable with an approved one. The FDA declared the semaglutide shortage resolved on February 21, 2025 and the tirzepatide shortage resolved in December 2024, so the shortage-era pathway for broad compounding of these drugs has ended. Compounding now proceeds under the ordinary rules: a 503A pharmacy compounding for an individual patient on a prescription, or a 503B outsourcing facility, which compounds in bulk under CGMP and FDA registration rather than per patient. Those rules generally do not cover a product that is “essentially a copy” of an approved drug unless a prescriber documents a change that makes a significant difference for an individual patient. Talk to a clinician about contraindications including personal or family history of medullary thyroid carcinoma or MEN 2. RangeYourself does not provide medical advice, does not guarantee a prescription, and does not guarantee weight-loss results.

RangeYourself is reader-supported. We may earn a commission when you click on certain links, at no extra cost to you. Editorial recommendations are made independently. Pricing reflects publicly listed entry tiers, verified on the dates shown in the table above, and may change. Numbers like Compounded, advertised from $119/mo (promo); recurring rate not consistently listed, confirm in enrollment and $158/mo (compounded semaglutide, 12-month plan; $249/mo month-to-month); medication and visits included are starting tiers, not your guaranteed long-term cost.